Source:http://linkedlifedata.com/resource/pubmed/id/15314039
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2004-9-20
|
pubmed:abstractText |
Recent work demonstrates that costimulatory molecules play a critical role for clonal deletion of autoreactive T cells in the thymus. The role of CD28 in the survival of autoreactive T cells in the periphery, however, has not been reported. Here we demonstrate that while mutation of the CD28 gene consistently increased the burden of autoreactive T cells in the thymus, such an increase was not always found in the periphery, as the CD28(-/-) autoreactive T cells disappeared in the spleen over a period between 4 and 10 weeks. The disappearance of autoreactive T cells associates with a diminished induction of Bcl-2 protein by the self antigen and an increased proportion of apoptotic cells in the periphery. Moreover, the elimination of autoreactive T cells in the periphery requires chronic stimulation by the self antigen, as adoptive transfer analysis revealed no enhancement of apoptosis in CD28(-/-) T cells in antigen-bearing hosts over a 3 day period. Thus, CD28 plays a significant role in both clonal deletion and survival of autoreactive T cells after chronic exposure to autoantigens, resulting in opposite effects on the burden of autoreactive T cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD28,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/tumor rejection antigen P815A, mouse
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0953-8178
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1403-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15314039-Age Factors,
pubmed-meshheading:15314039-Animals,
pubmed-meshheading:15314039-Antigens, CD28,
pubmed-meshheading:15314039-Antigens, Neoplasm,
pubmed-meshheading:15314039-Autoantigens,
pubmed-meshheading:15314039-Autoimmunity,
pubmed-meshheading:15314039-Clonal Deletion,
pubmed-meshheading:15314039-Flow Cytometry,
pubmed-meshheading:15314039-Mice,
pubmed-meshheading:15314039-Mice, Transgenic,
pubmed-meshheading:15314039-Mutation,
pubmed-meshheading:15314039-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:15314039-Spleen,
pubmed-meshheading:15314039-T-Lymphocytes,
pubmed-meshheading:15314039-Thymus Gland
|
pubmed:year |
2004
|
pubmed:articleTitle |
A new role for CD28 in the survival of autoreactive T cells in the periphery after chronic exposure to autoantigen.
|
pubmed:affiliation |
Division of Cancer Immunology, Department of Pathology, Ohio State University Medical Center, Columbus, OH 43210, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|